Answers are grounded in this paper and cite their sources.
Both 1.0 mg and 2.0 mg doses of Staccato alprazolam demonstrated efficacy in rapidly terminating seizures in an inpatient setting and were well tolerated. The next step is a Phase 3 confirmatory study to demonstrate efficacy and safety of Staccato alprazolam for rapid cessation of seizures in an outpatient setting.
No takes yet. Share an insight, caveat, or question.
French et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: